Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.

CAMS Oxford Institute unveiled at virtual ceremony. © Fisher Studios

The Vice-Chancellor of the University of Oxford formally unveiled the CAMS Oxford Institute (COI), a joint institute base in Oxford and supported by Oxford University and Chinese Academy of Medical Sciences/Peking Union Medical school.

The Institute will deliver outstanding science and help to develop innovative medicines to tackle infectious diseases and cancer.

The virtual event, hosted by The Nuffield Department of Medicine, on Oxford’s Old Road Campus, on Thursday 28th April, was attended by Chen Wang (President of CAMS/PUMC), Zeguang Zheng (Chinese Ambassador, Chinese Embassy London), Jianxue Sheng (Secretary General of China scholarship Council) and Xuetao Cao (President of Nankai University and Co-Director of COI).

Read the full story on the University of Oxford website. 

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.